Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ01
- Pharmacological subgroupJ01D
- Chemical subgroupJ01DD
- Chemical substanceJ01DD04Ceftriaxone
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 41 registrations
- Ceftriaxone for Injection1 G / VIAL · Powder For Solution · Fresenius Kabi Canada LTD
- Ceftriaxone for Injection2 G / VIAL · Powder For Solution · Fresenius Kabi Canada LTD
- Ceftriaxone for Injection100 G / BAG · Powder For Solution · Fresenius Kabi Canada LTD
- Ceftriaxone Injection, USP2000 MG / 50 ML · Solution · Baxter Corporation
Brazil
Anvisa · 28 registrations
At a glance
- ATC code
- J01DD04
- ATC group
- Anti-infectives for systemic use
- Registers
- 10
- Historical lists
- 2
- Registrations
- 263
- With their own page
- 131
- Companies
- 97
All medicines with Ceftriaxone
Human medicines from every register that match Ceftriaxone by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
269 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Ceftriaxone | United States | 1GM BASE/VIAL, 250MG BASE/VIAL, 2GM BASE/VIAL … | injectable | Marketed | Cephazone Pharma |
| Ceftriaxone | United States | 100GM BASE/VIAL, 10GM BASE/VIAL, 1GM BASE/VIAL … | injectable | Marketed | Fresenius Kabi USA |
| Ceftriaxone Sodium | United States | 10GM BASE/VIAL | injectable | Marketed | Hikma |
| Ceftriaxone-AFT | New Zealand | Inj 2 g vial | Funded | ||
| Ceftriaxone-AFT | New Zealand | Inj 1 g vial | Funded | ||
| Ceftriaxone-AFT | New Zealand | Inj 500 mg vial | Funded | ||
| Ceftriaxone in Plastic Container | United States | 20MG BASE/ML, 40MG BASE/ML | injectable | Marketed | Baxter Hlthcare |
| Ceftriaxone for Injection | Canada | 1 G / VIAL | Powder For Solution | Marketed | Fresenius Kabi Canada LTD |
| Ceftriaxone for Injection | Canada | 2 G / VIAL | Powder For Solution | Marketed | Fresenius Kabi Canada LTD |
| Ceftriaxone for Injection | Canada | 100 G / BAG | Powder For Solution | Marketed | Fresenius Kabi Canada LTD |
| Ceftriaxone Injection, USP | Canada | 1000 MG / 50 ML | Solution | Marketed | Baxter Corporation |
| Ceftriaxone Injection, USP | Canada | 2000 MG / 50 ML | Solution | Marketed | Baxter Corporation |
| Ceftriaxone and Dextrose in Duplex Container | United States | 1GM BASE/VIAL, 2GM BASE/VIAL | injectable | Marketed | B Braun |
| Ceftriaxone for Injection | Canada | 500 MG / VIAL | Powder For Solution | Authorised | Fresenius Kabi Canada LTD |
| Ceftriaxone for Injection | Canada | 10 G / VIAL | Powder For Solution | Authorised | Fresenius Kabi Canada LTD |
| Ceftriaxone Sodium for Injection BP | Canada | 250 MG / VIAL | Powder For Solution | Marketed | Sterimax INC |
| Ceftriaxone Sodium for Injection BP | Canada | 1 G / VIAL | Powder For Solution | Marketed | Sandoz Canada Incorporated |
| Ceftriaxone Sodium for Injection BP | Canada | 2 G / VIAL | Powder For Solution | Marketed | Sandoz Canada Incorporated |
| Ceftriaxone Sodium for Injection BP | Canada | 250 MG / VIAL | Powder For Solution | Marketed | Sandoz Canada Incorporated |
| Ceftriaxone Sodium for Injection BP | Canada | 10 G / VIAL | Powder For Solution | Marketed | Sandoz Canada Incorporated |
| Ceftriaxone Sodium for Injection BP | Canada | 2 G / VIAL | Powder For Solution | Marketed | Sterimax INC |
| Ceftriaxone Sodium for Injection BP | Canada | 10 G / VIAL | Powder For Solution | Marketed | Sterimax INC |
| Ceftriaxone Sodium for Injection BP | Canada | 1 G / VIAL | Powder For Solution | Marketed | Sterimax INC |
| Ceftriaxone Sodium for Injection BP | Canada | 500 MG / VIAL | Powder For Solution | Authorised | Sterimax INC |
| Ceftriaxone Kabi 2 g prašak za otopinu za infuziju | Croatia | prašak za otopinu za infuziju | Marketed | Fresenius Kabi d.o.o. |